智通财经网·2025-10-16 03:59Group 1 - The pharmaceutical sector continues its upward trend, with notable stock increases for companies such as Qianxin Biotech-B (up 7.04%), Fuhong Hanlin (up 6.84%), and others [1] - The upcoming European Society for Medical Oncology (ESMO) conference from October 17 to 21, 2025, in Berlin is expected to showcase significant clinical research results and related clinical data [1] - Despite a slight decrease in the proportion of domestic capital holding pharmaceutical stocks through the Hong Kong Stock Connect, the overall trend of increasing investment in innovative drugs remains unchanged [1] Group 2 - The ESMO annual meeting is anticipated to highlight clinical data for Chinese innovative drugs, which is expected to be a major focus for the market [2] - The third-quarter earnings reports and the national medical insurance negotiations in November are also recommended for attention [2] - The trend of Chinese innovative drugs is expected to undergo a transformation driven by factors such as international business development, continuous data catalysts, and the ramp-up of new product sales over the next 5-10 years [2]